News
Zepbound beats Wegovy for weight loss
Digest more
The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...
Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...
GLP-1 drug Zepbound leads to greater weight and waist loss than Wegovy in 72-week trial, say researchers at European Congress ...
In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro ...
In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback